References
- The European Pharmacopoeia. 6th edition. Vol. 1. Strasbourg Cedex: Directorate for the Quality of the Medicines & HealthCare of the Council of Europe (EDQM).
- Agarwal V, Kothari BH, Moe DV, Khankari RK. (2007). Drug delivery: Fast-dissolve systems. In: Swarbric J, ed. Encyclopedia of Pharmaceutical Technology. 3rd edition. New York: Informa Healthcare USA, Inc, 1104–1114.
- Guidance for industry: Orally disintegrating tablets. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), December 2008, Chemistry. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070578.pdf. Accessed on: 20 Dec 2010.
- Watanabe Y, Koizumi K, Zama Y, Kiriyama M, Matsumoto Y, Matsumoto M. New compressed tablet rapidly disintegrating in saliva in the mouth using crystalline cellulose and a disintegrant. Biol Pharm Bull 1995;18:1308–1310.
- Bi Y, Sunada H, Yonezawa Y, Danjo K, Otsuka A, Iida K. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull 1996;44:2121–2127.
- Sunada H, Bi Y. Preparation, evaluation and optimization of rapidly disintegrating tablets. Powder Technol 2002;122:188–198.
- Dor PJ, Fix JA. In vitro determination of disintegration time of quick-dissolve tablets using a new method. Pharm Dev Technol 2000;5:575–577.
- Abdelbary G, Eouani C, Prinderre P, Joachim J, Reynier J, Piccerelle P. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Int J Pharm 2005;292:29–41.
- Ohta M, Hayakawa E, Ito K, Tokuno S, Morimoto K, Watanabe Y. US Patent Application 2001/0014340 A1, 2001. Available at: http://www.freepatentsonline.com/y2001/0014340.html. Accessed on: 08 Sep 2011.
- Fang F, Adams R, Hahm HA. Desktop disintegration test for orally disintegrating tablets (ODT’s): A rapid and simple method for observing the disintegration behavior for the regulatory review scientists in the evaluation of drug applications. FDA Science Forum 2006, K-14.
- Morita Y, Tsushima Y, Yasui M, Termoz R, Ajioka J, Takayama K. Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera. Chem Pharm Bull 2002;50:1181–1186.
- Narazaki R, Harada T, Takami N, Kato Y, Ohwaki T. A new method for disintegration studies of rapid disintegrating tablet. Chem Pharm Bull 2004;52:704–707.
- Harada T, Narazaki R, Nagira S, Ohwaki T, Aoki S, Iwamoto K. Evaluation of the disintegration properties of commercial famotidine 20 mg orally disintegrating tablets using a simple new test and human sensory test. Chem Pharm Bull 2006;54:1072–1075.
- Harada T, Uchida T, Yoshida M, Kobayashi Y, Narazaki R, Ohwaki T. A new method for evaluating the bitterness of medicines in development using a taste sensor and a disintegration testing apparatus. Chem Pharm Bull 2010;58:1009–1014.
- Gal JY, Fovet Y, Adib-Yadzi M. About a synthetic saliva for in vitro studies. Talanta 2001;53:1103–1115.
- BASF. (2007). Ludiflash® brochure. Available at: http://www.pharma-solutions.basf.com. Accessed on: 22 Feb 2010.